115 related articles for article (PubMed ID: 1382257)
1. Subclinical hepatocellular carcinoma in Hong Kong Chinese.
Lai CL; Lau JY; Wu PC; Hui WM; Lai EC; Fan ST; Ngan H; Lin HJ
Oncology; 1992; 49(5):347-53. PubMed ID: 1382257
[TBL] [Abstract][Full Text] [Related]
2. Subclinical hepatocellular carcinoma: an analysis of 391 patients.
Tang ZY; Yu YQ; Zhou XD; Yang BH; Ma ZC; Lin ZY
J Surg Oncol Suppl; 1993; 3():55-8. PubMed ID: 7684916
[TBL] [Abstract][Full Text] [Related]
3. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience.
Yuen MF; Cheng CC; Lauder IJ; Lam SK; Ooi CG; Lai CL
Hepatology; 2000 Feb; 31(2):330-5. PubMed ID: 10655254
[TBL] [Abstract][Full Text] [Related]
4. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Yao M; Zhao J; Lu F
Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
[TBL] [Abstract][Full Text] [Related]
5. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis.
Poon RT; Fan ST; Lo CM; Liu CL; Ng IO; Wong J
J Clin Oncol; 2000 Mar; 18(5):1094-101. PubMed ID: 10694562
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
7. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.
Zhang Q; Shang L; Zang Y; Chen X; Zhang L; Wang Y; Wang L; Liu Y; Mao S; Shen Z
Eur J Gastroenterol Hepatol; 2014 May; 26(5):544-52. PubMed ID: 24614696
[TBL] [Abstract][Full Text] [Related]
8. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
McMahon BJ; Bulkow L; Harpster A; Snowball M; Lanier A; Sacco F; Dunaway E; Williams J
Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632
[TBL] [Abstract][Full Text] [Related]
9. Small and asymptomatic hepatocellular carcinoma detected by alpha-fetoprotein screening in black hepatitis B carriers. A report of 2 cases.
Dusheiko GM; Conradie JC; Bowyer SM; Simjee A; Epstein B; Levien LJ; Beale P; Kew MC
S Afr Med J; 1986 Jan; 69(2):129-32. PubMed ID: 2417341
[TBL] [Abstract][Full Text] [Related]
10. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
[TBL] [Abstract][Full Text] [Related]
11. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
[TBL] [Abstract][Full Text] [Related]
12. Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.
Wang N; Cao Y; Song W; He K; Li T; Wang J; Xu B; Si HY; Hu CJ; Li AL
J Gastroenterol Hepatol; 2014; 29(7):1544-50. PubMed ID: 24612022
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma in southern Germany: epidemiological and clinicopathological characteristics and risk factors.
Hellerbrand C; Hartmann A; Richter G; Knöll A; Wiest R; Schölmerich J; Lock G
Dig Dis; 2001; 19(4):345-51. PubMed ID: 11935095
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis].
Lee HY; Jung JH; Kang YS; Kim YS; Moon HS; Park KO; Lee YS; Kim SM; Seo SW; Lee SW; Kim SH; Lee BS; Kim NJ
Korean J Gastroenterol; 2004 Apr; 43(4):252-9. PubMed ID: 15100489
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in liver cirrhosis. A prospective study.
Imberti D; Fornari F; Sbolli G; Buscarini E; Squassante L; Buscarini L
Scand J Gastroenterol; 1993 Jun; 28(6):540-4. PubMed ID: 7686686
[TBL] [Abstract][Full Text] [Related]
16. [Screening for hepatocellular carcinoma].
Leone N; Rizzetto M
Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
[TBL] [Abstract][Full Text] [Related]
17. Markers for hepatocellular carcinoma.
Wu AH; Sell S
Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a surveillance program for early detection of hepatocellular carcinoma.
Zoli M; Magalotti D; Bianchi G; Gueli C; Marchesini G; Pisi E
Cancer; 1996 Sep; 78(5):977-85. PubMed ID: 8780534
[TBL] [Abstract][Full Text] [Related]
19. Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: a prospective study.
Cottone M; Turri M; Caltagirone M; Maringhini A; Sciarrino E; Virdone R; Fusco G; Orlando A; Marino L; Pagliaro L
Hepatogastroenterology; 1988 Jun; 35(3):101-3. PubMed ID: 2456973
[TBL] [Abstract][Full Text] [Related]
20. Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time.
Lee E; Edward S; Singal AG; Lavieri MS; Volk M
Clin Gastroenterol Hepatol; 2013 Apr; 11(4):437-40. PubMed ID: 23247324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
